Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EDIT Editas Medicine, Inc.

盘后交易 07-22 19:25:51 EDT

2.78

-0.11

-3.81%

盘后2.79

+0.01+0.36%

17:28 EDT

最高2.89	最低2.73	成交量103.73万
今开2.85	昨收2.89	日振幅5.36%
总市值4.25亿	流通市值3.94亿	总股本1.53亿
成交额286.93万	换手率0.73%	流通股本1.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine, Inc.","latestPrice":2.78,"timestamp":1784750400000,"preClose":2.89,"halted":0,"volume":1037301,"hourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.78,"latestTime":"17:28 EDT","volume":44825,"amount":124613.67033499999,"timestamp":1784755712639,"change":0.01,"changeRate":0.003597,"amplitude":0.02518},"delay":0,"changeRate":-0.03806228373702433,"floatShares":141837682,"shares":153000000,"eps":-1.178492,"marketStatus":"盘后交易","change":-0.11,"latestTime":"07-22 19:25:51 EDT","open":2.85,"high":2.885,"low":2.7301,"amount":2869268.3380104,"amplitude":0.053599,"askPrice":2.85,"askSize":700,"bidPrice":2.72,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.178492,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784764800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.89,"preHourTrading":{"tag":"盘前","latestPrice":2.8617,"preClose":2.89,"latestTime":"09:15 EDT","volume":183,"amount":522.9413124,"timestamp":1784726159987,"change":-0.0283,"changeRate":-0.009792,"amplitude":0.00436},"postHourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.78,"latestTime":"17:28 EDT","volume":44825,"amount":124613.67033499999,"timestamp":1784755712639,"change":0.01,"changeRate":0.003597,"amplitude":0.02518},"volumeRatio":0.711783,"impliedVol":1.454,"impliedVolPercentile":0.753},"requestUrl":"/m/hq/s/EDIT","defaultTab":"news","newsList":[{"id":"2645819136","title":"基因编辑概念普升 安捷伦科技(A)领涨4.21% 机构指美国FDA相关疗法审评新规利好相关标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819136","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645819136?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:21","pubTimestamp":1782310862,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美股基因编辑概念普升，截至发稿，安捷伦科技 (A) 涨 4.21%，Beam Therapeutics (BEAM) 涨 3.55%，Intellia Therapeutics (NTLA) 涨 2.95%，Editas Medicine (EDIT) 涨 2.17%，福泰制药 (VRTX) 涨 1.28%。消息面上，建银国际新近研究认为，美国FDA近期发布了基因编辑疗法审评新规，允许药企在提供充分科学可比性论证的前提下，引用“先验知识”或既往成熟研究数据以加速研发，此举这标志着基因编辑疗法审评思路的重要转变，直接利好拥有相关技术平台的企业。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301875","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTLA","LU2462157665.USD","LU0889565916.HKD","LU2362540622.SGD","EDIT","LU1861559042.SGD","LU2092937221.SGD","LU0234570918.USD","LU2413666699.HKD","BK4611","SG9999001176.SGD","LU2229751404.USD","BEAM","LU2236285917.USD","LU2041044095.USD","BK4505","LU1585245621.USD","BK4588","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU0256863811.USD","LU1674673691.USD","LU0058720904.USD","LU0079474960.USD","IE00B894F039.SGD","LU2324357040.USD","VRTX","IE00B19Z3581.USD","LU2089279066.USD","IE00BJT1NW94.SGD","LABU","LU2362541273.HKD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","A","BK4533","LU1035775433.USD","SG9999013999.USD","BK4121","LU1861558580.USD","BK4139","LU0109394709.USD","LU0432979614.USD","LU1674673428.USD","SGXZ57979304.SGD","IE00BN0W2W23.USD","LU0417517546.SGD","BK4567","IE00BN0W2V16.EUR","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161976908","title":"Editas Medicine在2026年美国基因与细胞治疗学会年会上公布新临床前数据，展示Edit-401作为高脂血症潜在疗法的进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1161976908","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161976908?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:04","pubTimestamp":1778753042,"startTime":"0","endTime":"0","summary":"Editas Medicine, Inc. (EDIT) 在2026年美国基因与细胞治疗学会年会上公布了新的临床前数据，这些数据展示了其研究性疗法Edit-401作为治疗高脂血症潜在方案的进展。报告内容突显了该疗法在临床前模型中的有效性与作用机制，为其后续的临床开发路径提供了支持依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613974315","title":"Editas Medicine, Inc.盘中异动 股价大涨6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613974315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613974315?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:33","pubTimestamp":1771943586,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时33分，Editas Medicine, Inc.股票出现波动，股价快速拉升6.88%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Larimar Therapeutics, Inc.、Biorestorative Therapies, Inc.、Palvella Therapeutics, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Silo Pharma, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为223.03%、164.27%、153.31%，振幅较大的相关个股有Maia Biotechnology, Inc.、Edesa Biotech, Inc.、Cardio Diagnostics Holdings Inc.，振幅分别为100.00%、12.24%、11.63%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223306a4c36c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223306a4c36c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609956841","title":"Editas Medicine, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609956841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609956841?lang=zh_cn&edition=full","pubTime":"2026-02-05 23:02","pubTimestamp":1770303740,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日23时02分，Editas Medicine, Inc.股票出现异动，股价快速下跌5.13%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Bone Biologics Corp C/Wts 13/10/2026 涨幅较大，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为1612.83%、1023.21%、208.77%，振幅较大的相关个股有Aim Immunotech Inc.、Liminatus Pharma, Inc.、Bone Biologics Corp C/Wts 13/10/2026 ，振幅分别为51.18%、30.07%、28.16%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523022095400385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523022095400385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607027457","title":"Editas Medicine, Inc.盘中异动 大幅下挫5.10%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607027457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607027457?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:59","pubTimestamp":1769785178,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日22时59分，Editas Medicine, Inc.股票出现异动，股价快速跳水5.10%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Vivosim Labs, Inc.、Promis Neurosciences Inc.、Briacell Therapeutics Corp C/Wts 涨幅较大，Vivosim Labs, Inc.、Promis Neurosciences Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1191.42%、293.24%、39.22%，振幅较大的相关个股有Promis Neurosciences Inc.、阿诺医药、Briacell Therapeutics Corp C/Wts ，振幅分别为37.98%、35.22%、31.63%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130225938a6c0c192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130225938a6c0c192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605145816","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.17%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605145816?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:33","pubTimestamp":1768919591,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时33分，Editas Medicine, Inc.股票出现波动，股价急速下跌5.17%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Jaguar Health, Inc.、Dermata Therapeutics, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为58.22%、46.10%、43.57%，振幅较大的相关个股有Immunitybio, Inc.、Aclaris Therapeutics, Inc.、Corvus Pharmaceuticals, Inc.，振幅分别为15.04%、14.50%、13.79%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223311a731080b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223311a731080b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189860844","title":"Edita食品与Hostess Brands签署销售转让协议，扩大非洲品牌版图","url":"https://stock-news.laohu8.com/highlight/detail?id=1189860844","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189860844?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:20","pubTimestamp":1768461639,"startTime":"0","endTime":"0","summary":"埃及食品巨头Edita Food Industries近日宣布与Hostess Brands达成一项销售与转让协议。根据协议内容，Edita将获得HoHos、Twinkies和Tiger Tail等知名品牌在非洲大陆剩余国家的商标权、品牌名称及商誉。\n此次收购标志着Edita在品牌全球化战略上的重要推进。值得注意的是，该公司此前已拥有这些品牌在中东和北非地区的商标权与品牌名称。新协议的签署使其品牌控制范围进一步扩展至非洲其他区域。\n通过整合跨区域品牌资源，Edita有望强化其在非洲市场的品牌影响力。此次交易将为公司创造更广泛的商业协同效应，提升其在全球零食行业的竞争壁垒。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","BK4556","SJM","BK4585","BK4588","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603647346","title":"Editas Medicine, Inc.盘中异动 早盘快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603647346?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:07","pubTimestamp":1768403240,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时07分，Editas Medicine, Inc.股票出现异动，股价急速拉升5.26%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114230720a4c3cd2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114230720a4c3cd2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518748472","title":"Editas Medicine, Inc.盘中异动 股价大跌5.52%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518748472?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:51","pubTimestamp":1741618295,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时51分，Editas Medicine, Inc.股票出现波动，股价急速跳水5.52%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3498.05%、774.19%、704.07%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.34%、41.36%、40.33%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225135a26a4357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225135a26a4357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518816852","title":"Editas Medicine, Inc.2024财年实现净利润-2.37亿美元，同比减少54.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518816852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518816852?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536055,"startTime":"0","endTime":"0","summary":"3月10日，Editas Medicine, Inc.公布财报，公告显示公司2024财年净利润为-2.37亿美元，同比减少54.90%；其中营业收入为32.31百万美元，同比减少58.64%，每股基本收益为-2.88美元。从资产负债表来看，Editas Medicine, Inc.总负债2.07亿美元，其中短期债务14.65百万美元，资产负债比为1.66，流动比率为0.04。机构评级：截至2025年3月10日，当前有9家机构对Editas Medicine, Inc.目标价做出预测，其中目标均价为3.78美元，其中最低目标价为1.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000132a2689825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000132a2689825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517768920","title":"Editas Medicine(EDIT.US)：2024年Q4财报实现营收3060.4万美元，前值为6005万美元，预期值为3223万美元；每股收益为-0.40美元，前值为-0.23美元，预期值为-0.38美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517768920","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517768920?lang=zh_cn&edition=full","pubTime":"2025-03-06 06:42","pubTimestamp":1741214545,"startTime":"0","endTime":"0","summary":"Editas Medicine(EDIT.US)：2024年Q4财报实现营收3060.4万美元，前值为6005万美元，预期值为3223万美元；每股收益为-0.40美元，前值为-0.23美元，预期值为-0.38美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06064248551559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110726487","title":"Editas Medicine 2024年第四季度GAAP每股亏损$0.55,不及预期$0.38，销售额$30.604M不及预期$32.230M","url":"https://stock-news.laohu8.com/highlight/detail?id=1110726487","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110726487?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:11","pubTimestamp":1741209086,"startTime":"0","endTime":"0","summary":"Editas Medicine  报告季度每股亏损$0.55，低于分析师普遍预期的$0.38，相差44.74%。与去年同期每股亏损$0.23相比，这是一个139.13%的下降。以上内容来自Benzinga Earnings专栏，原文如下：Editas Medicine  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 44.74 percent. This is a 139.13 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $30.604 million which missed the analyst consensus estimate of $32.230 million by 5.04 percent.  This is a 49.04 percent d","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Editas Medicine 2024年第四季度GAAP每股亏损$0.55,不及预期$0.38，销售额$30.604M不及预期$32.230M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948568","title":"Editas Medicine, Inc.盘中异动 股价大涨5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948568?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185053,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.11%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为311.45%、251.30%、184.61%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223053abe9b054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223053abe9b054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516583936","title":"Editas Medicine, Inc.盘中异动 早盘大幅下跌5.15%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516583936?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:33","pubTimestamp":1741016000,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时33分，Editas Medicine, Inc.股票出现波动，股价大幅下跌5.15%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2111.16%、136.36%、127.52%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514188860","title":"Editas Medicine, Inc.盘中异动 早盘快速下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514188860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514188860?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493905,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Editas Medicine, Inc.股票出现波动，股价急速下跌5.44%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为748.84%、541.52%、462.86%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为62.33%、19.20%、8.87%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223145a25386ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223145a25386ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513496720","title":"Editas Medicine, Inc.盘中异动 早盘急速跳水5.73%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513496720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513496720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:52","pubTimestamp":1740408766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时52分，Editas Medicine, Inc.股票出现异动，股价快速跳水5.73%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为132.80%、54.81%、25.03%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225246962e9e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225246962e9e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513144296","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨12.62%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513144296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513144296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148277,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Editas Medicine, Inc.股票出现异动，股价快速拉升12.62%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.10%、60.32%、17.96%，振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为14.17%、10.21%、7.71%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223117a24eb010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223117a24eb010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512483685","title":"Editas Medicine, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512483685?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:35","pubTimestamp":1739975756,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时35分，Editas Medicine, Inc.股票出现异动，股价大幅拉升5.17%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为259.20%、205.80%、66.76%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Azitra Inc，振幅分别为207.68%、19.64%、16.40%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223557988b3226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223557988b3226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165037","title":"Editas Medicine, Inc.盘中异动 股价大涨5.88%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165037?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889172,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.88%。截至发稿，该股报1.46美元/股，成交量26.1401万股，换手率0.32%，振幅3.26%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232529889fcf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232529889fcf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2511577844","title":"Editas Medicine, Inc.盘中异动 临近收盘大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511577844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511577844?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:50","pubTimestamp":1739479814,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时50分，Editas Medicine, Inc.股票出现异动，股价急速拉升5.04%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3288.24%、2317.37%、1269.38%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045014a244f569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045014a244f569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.editasmedicine.com","stockEarnings":[{"period":"1week","weight":-0.0854},{"period":"1month","weight":0.0743},{"period":"3month","weight":-0.1321},{"period":"6month","weight":0.2143},{"period":"1year","weight":-0.0825},{"period":"ytd","weight":0.4098}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0021},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.0973}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立，后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司，致力于通过纠正患者的致病基因治疗与基因相关的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.048743},{"month":2,"riseRate":0.5,"avgChangeRate":0.075357},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.053873},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.002841},{"month":5,"riseRate":0.545455,"avgChangeRate":0.014988},{"month":6,"riseRate":0.545455,"avgChangeRate":0.075904},{"month":7,"riseRate":0.636364,"avgChangeRate":0.022524},{"month":8,"riseRate":0.6,"avgChangeRate":0.036188},{"month":9,"riseRate":0.2,"avgChangeRate":-0.076361},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058936},{"month":11,"riseRate":0.5,"avgChangeRate":0.071042},{"month":12,"riseRate":0.3,"avgChangeRate":0.023099}],"exchange":"NASDAQ","name":"Editas Medicine, Inc.","nameEN":"Editas Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Editas Medicine, Inc.,EDIT,Editas Medicine, Inc.股票,Editas Medicine, Inc.股票老虎,Editas Medicine, Inc.股票老虎国际,Editas Medicine, Inc.行情,Editas Medicine, Inc.股票行情,Editas Medicine, Inc.股价,Editas Medicine, Inc.股市,Editas Medicine, Inc.股票价格,Editas Medicine, Inc.股票交易,Editas Medicine, Inc.股票购买,Editas Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}